STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying...

Related Keywords

Germany ,Boston ,Massachusetts ,United States ,Tokyo ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Joanna Obacz ,Jerry Mcmahon ,Alexandra Sapetschnig ,Marie Carkill ,Oliver Rausch ,Claire Saunders ,Mark Albertella ,Josefin Beate Holz ,Lina Vasiliauskaite ,Society For Immunotherapy Of Cancer ,Therapeutics Ltd ,Society For Immunotherapy Of Cancer Annual Meeting ,Merck Kga ,Ip Group ,Fast Track Initiative ,Merck Kgaa ,University Of Tokyo Innovation Platform ,Seroba Life Sciences ,Molecular Targets ,Cancer Therapeutics Symposium ,New Therapies ,Presentation Title ,Presentation Number ,Yaara Ofir ,Georgia Tsagkogeorga ,Jezrom Self Fordham ,Annual Meeting ,Novel Single Agent ,Pfizer Ventures ,Taiho Ventures ,Cambridge Innovation Capital ,Tokyo Innovation ,Cancer Therapeutics ,Cancer Annual ,Pre Conference Programs ,Storm Therapeutics ,